Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
J Clin Invest. 2024 Oct 15;134(20):e184326. doi: 10.1172/JCI184326.
Kidney transplantation from donors with HIV to recipients with HIV (HIV D+/R+) is an emerging practice that has shown substantial clinical benefit. Sustained HIV superinfection, whereby a transplant recipient acquires a new strain of HIV from their organ donor, is a theoretical risk, which might increase chances of viral failure. In this issue of the JCI, Travieso, Stadtler, and colleagues present phylogenetic analysis of HIV from kidney tissue, urine, plasma, and cells from 12 HIV D+/R+ kidney transplants out to five years of follow-up. Early after transplant, donor HIV was transiently detected in five of 12 recipients, primarily from donors with untreated HIV and high-level viremia, consistent with a viral inoculum. Long-term, donor HIV was not detected in any recipients, demonstrating no sustained HIV superinfection. These reassuring data support earlier findings from South Africa and the United States and further confirm the safety of HIV D+/R+ transplantation.
HIV 阳性供者向 HIV 阳性受者(HIV D+/R+)进行肾移植是一种新兴的实践,已显示出显著的临床获益。持续性 HIV 再感染是指受者从供者器官中获得新的 HIV 毒株,这是一种理论上的风险,可能会增加病毒失败的几率。在本期 JCI 中,Travieso、Stadtler 和同事们对 12 例 HIV D+/R+肾移植后长达 5 年的肾组织、尿液、血浆和细胞中的 HIV 进行了系统发育分析。移植后早期,在 12 例受者中的 5 例中检测到供者 HIV 一过性存在,主要来自未经治疗且病毒载量较高的供者,与病毒接种物一致。长期随访中,未在任何受者中检测到供者 HIV,表明不存在持续性 HIV 再感染。这些令人安心的数据支持了来自南非和美国的早期发现,并进一步证实了 HIV D+/R+移植的安全性。